iodine. From these data it is not possible to evaluate the risks of the iodine treatment because the total number of patients treated in this way, which must be very large, is not known. Furthermore, they are obviously a highly selected group as far as thyroid function and pathology are concerned and may well have a higher risk of thyroid cancer unrelated to the irradiation.
From the Japanese atomic bomb survivors, data reported by Sampson et al. (1969) show that about 18 % of those selected for a life-span study who come to autopsy have primary thyroid cancers, as diagnosed by serial section of the thyroid. In the selected group of survivors who were in the 0-10 years age group at the time of the bomb (Jablon et al. 1971) , thyroid cancer incidence at present appears to be about equal to the leukaemia incidence. In older age groups thyroid cancer is less evident and this may indicate a higher sensitivity to radiation-induced thyroid cancer in young people.
Of the 18 children below the age of 10 years on the Marshall Islands when they were exposed to external radiation of about 175 rad and radioiodine doses to the thyroid of between 700 and 1400 rad, only 2 have normal thyroid function 15 years later, 13 have had surgery for nodular thyroids and one papillary adenoma has been found (Conard et al. 1970) . In 34 adults, one person has had an operation for nodular thyroid and one papillary carcinoma has been found.
In conclusion, there is now considerable evidence that irradiation of the thyroid increases the risk of thyroid cancer, particularly in young people. Most of this evidence comes from persons who have received external radiation and consequently other organs, such as the thymus, may have been irradiated simultaneously and this may influence the onset of the thyroid cancer. Unfortunately it is not possible to evaluate from the published data the risk ofthyroid cancer following administration of iodine-131 where the radiation dose is mainly confined to the gland. It is hoped that more follow-up surveys of patients who have received iodine-131 for diagnosis or treatment will be carried out, although the interpretation of such surveys in terms of cancer risk will be distorted because these patients are selected for thyroid malfunction. 
Value of Scanning in Diagnosis and Treatment of Thyroid Cancer
The thyroid scan is rarely of much help in the diagnosis of thyroid carcinoma. A scan may be requested in a patient with a solitary thyroid nodule; the majority of such lesions including carcinoma are 'cold' on the scan; if the nodule is 'hot' this probably excludes carcinoma, but otherwise a pathological diagnosis cannot be made. A thyroid scan may also be requested in a patient with metastases in whom the site of the primary is unknown; in this situation an abnormal scan does not necessarily indicate a primary carcinoma, while it is extremely rare for metastases from thyroid carcinoma to take up iodine in the presence of normal thyroid tissue in the body.
Treatment with radioactive iodine should be considered in all patients with differentiated thyroid carcinoma in whom there is doubt whether complete surgical removal of the disease has been effected. Scanning is essential in these patients to determine their suitability for radioactive iodine therapy. Prior to scanning all normal thyroid tissue must be removed or destroyed. Thyroid ablation is best effected by total thyroidectomy, but if this operation has not been possible or is considered inadvisable, then 80 millicuries of 1811 must be given to destroy the remaining thyroid tissue.
Following thyroid ablation a scan is performed to demonstrate iodine uptake in residual tumour. A tracer dose of 1 mCi 18Il is given followed by a whole-body scan three days later. The whole-body scan has the advantage over the profile scan of delineating areas of tumour and distinguishing them from uptake in normal tissues such as the salivary glands, stomach and rectum. In addition, the whole-body scan can give a quantitative estimate of the concentration of iodine by the tumour, and hence it can be calculated whether it is likely that a lethal dose of radiation can be delivered to the tumour cells by the maximum quantity of radioactive iodine that can safely be administered. Demonstration of tumour uptake on a scan is not in itself a clear indication for radioactive iodine therapy; there must be an adequate concentration of the iodine for this method of treatment to be preferred.
The whole-body scan may demonstrate uptake in residual tumour in the neck or in distant metastases, or both. In a patient with residual carcinoma clinically confined to the neck the scan may quite often show occult metastases not detectable clinically or radiologically. In Cardiff between 1967 and 1971 10 such patients were subjected to radioiodine ablation of the normal thyroid gland followed by scanning; occult metastases were detected in no less than 5. There were 6 cases of papillary carcinoma, of whom 4 showed uptake in the lungs with a normal chest X-ray; in all these cases the lung uptake disappeared after radioiodine therapy. There were 4 cases of follicular carcinoma; one showed uptake in the lungs which disappeared after radioiodine therapy, another showed uptake in the lumbar spine. In the latter case there was no response to radioiodine therapy, and six months after scanning a sclerotic metastasis in the 5th lumbar vertebra became visible on X-ray.
The frequent finding of occult metastases suggests that in a patient with inoperable or residual differentiated thyroid carcinoma clinically confined to the neck, radioiodine therapy should be preferred to external beam radiotherapy provided adequate tumour uptake can be demonstrated on the scan.
Mr Selwyn Taylor (RoyalPostgraduate Medical School, Hammersmith Hospital, London W12 OHS)
Thyroid Cancer: Surgical Methods and Treatment -Their Indications and Value The surgical operations that are called for in treating thyroid cancer are biopsy, lobectomy, total thyroidectomy and removal of metastases, especially involved lymph nodes in the neck and mediastinum. The indications for these operations are dealt with according to the mode of clinical presentation. It should be remembered, however, that in no other organ does the pathological *diagnosis have such overriding importance in the surgeon's decision on what he should remove.
The Solitary Nodule This lesion is common in all parts of the world and at all ages, but is much more common where the iodine intake is deficient. If a thyroid nodule feels truly solitary then there is a possibility that it may be malignant. At Hammersmith Hospital the incidence of thyroid cancer in such lesions is 12% but the clinical diagnosis of solitary is only correct in about half of these patients, the remainder being found to have multiple nodules at operation. The incidence of carcinoma is higher if these nodules are scanned using radioactive iodine and only the cold ones are excised. It has often been pointed out that if a solitary nodule is seen in a child, or in a very old patient for the first time, the likelihood of malignancy is much higher than it is in middle age. The reason for this is not that thyroid cancer has a particularly high incidence at the extremes of life, but that simple nodules occur very commonly in middle age. In a consecutive series of 207 clinically solitary nodules excised at Hammersmith there were 26 carcinomas; all were differentiated, 15 papillary and 11 follicular.
I advise that all solitary nodules in the thyroid gland shown by scanning to be cold should be excised, and if the patient is very young or very old the operation should be performed as soon as possible. The operation takes the form of a lobectomy which removes the entire lesion with its capsule and surrounding thyroid. The isthmus and a flake of tissue is removed from the opposite lobe so that if later there is compensatory hyperplasia it will not be so noticeable. If a lymph node appears enlarged or suspiciously hard it is sent immediately for frozen section, since, if it contains a metastatic deposit a more extensive operation should be done.
Diffuse or Multinodular Lesions
There are good indications which glands are likely to harbour a malignant lesion. If a goitre grows rapidly it should arouse suspicion, especially in the older patient, i.e. over 65. If it feels hard or craggy, or if it shows any degree of fixation this raises the real possibility of malignancy, while hoarseness due to involvement of a recurrent nerve is almost pathognomonic of carcinoma. If the disease process involving the thyroid gland is diffuse it is justifiable to perform a drill biopsy or to use a split needle technique. A reasonable sample is obtained and can be reported on within 48 hours. There is certainly no justification for performing a drill biopsy on a solitary nodule, which should be excised entire. An aggressive Hashimoto thyroiditis can mimic carcinoma, including production of slight hoarseness. Rarely deQuervain thyroiditis produces a hard knobbly gland. In the older patient if the gland enlarges rapidly and there is the possibility of an anaplastic lesion, a drill biopsy offers an ideal way of making the diagnosis before referring the patient for radiation therapy.
Lymph Node Enlargement Many thyroid carcinomas are first diagnosed when a young patient with palpable lymph nodes
